Signal #149869 · SEC 8-K

$CRVS SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $CRVS filing catalyst

Why did $CRVS trigger an AI stock catalyst alert?

$CRVS triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.5/10). Headline: Corvus Pharmaceuticals Reports Widened Q3 Net Loss of $20.3M. Key points: - Net loss doubled year-over-year to $20.3 million ($0.22 per share) vs $10.2 million ($0.12 per share) in Q3 2025. - Operating expenses climbed to $21.4 million driven by pipeline advancement. - Cash and equivalents stood at $202.9 million, providing runway into Q2 2028.

How did $CRVS stock react after the SEC filing?

After the SEC 8-K for $CRVS, observed market reaction: T0 price $9.73. Past moves do not guarantee future results.

Where can I get real-time $CRVS SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $CRVS via Telegram and the VIP Web Terminal from €10/month.

$CRVS

$CRVS – Corvus Pharmaceuticals Reports Widened Q3 Net Loss of $20.3M

Corvus Pharmaceuticals, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $CRVS

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-1.5 / 10)

Net loss doubled year-over-year to $20.3 million ($0.22 per share) vs $10.2 million ($0.12 per share) in Q3 2025.
Operating expenses climbed to $21.4 million driven by pipeline advancement.
Cash and equivalents stood at $202.9 million, providing runway into Q2 2028.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →